Management strategies for vasovagal syncope.

Ali, Muzaffar; Pachon Maetos, Jose Carlos; Kichloo, Asim; Masudi, Sundas; Grubb, Blair P; Kanjwal, Khalil

Ali, Muzaffar; Pachon Maetos, Jose Carlos; Kichloo, Asim; Masudi, Sundas; Grubb, Blair P; Kanjwal, Khalil.

Afiliación

Ali M; Sheri Kashmir Institute, Department of Cardiology, Srinagar, Jammu and Kashmir, India.
Pachon Maetos JC; University of São Paulo, Department of cardiology, São Paulo, Brazil.
Kichloo A; Central Michigan University, Internal Medicine, Saginaw, Michigan, USA.
Masudi S; Samaritan Medical Center, Internal Medicine, Watertown, New York, USA.
Grubb BP; University of Liverpool School of Medicine, Liverpool, UK.
Kanjwal K; Division of cardiology, University of Toledo, Toledo, Ohio, USA.

Pacing Clin Electrophysiol ; 44(12): 2100-2108, 2021 Dec.

Article en En | MEDLINE | ID: mdl-34748224

ABSTRACT

ABSTRACT

Vasovagal syncope (VVS) (or neurocardiogenic syncope) is a common clinical condition that is challenging to both physicians and patients alike. Severe episodes of recurrent syncope can result in physical injury as well as psychological distress. This article provides a brief overview of current management strategies and a detailed overview of therapeutic modalities such as closed loop stimulation (CLS) and cardioneuroablation (CNA).

Asunto(s)

Síncope Vasovagal/terapia; Técnicas de Ablación; Algoritmos; Estimulación Cardíaca Artificial; Diagnóstico Diferencial; Humanos; Calidad de Vida; Síncope Vasovagal/diagnóstico; Síncope Vasovagal/etiología

Palabras clave

cardioneuroablation (CNA); dysautonomia; syncope; vasovagal syncope (VVS)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síncope Vasovagal Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google